Afficher la couverture 'Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes | Petit, Jean-Michel' en grand format
/5

0 avis

Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes

Archive ouverte

Petit, Jean-Michel | Bouillet, Benjamin | Loffroy, Romaric | Rouland, Alexias | Hillon, Patrick | Verges, Bruno

Edité par CCSD ; Elsevier -

IF 12.486. Lettre à l'éditeur ("Journal of Hepatology", vol. 68, n°3, pp. 603-604, available online 4 October 2017)https://www.sciencedirect.com/science/article/pii/S0168827817323292?via%3Dihub

Consulter en ligne

Suggestions

Du même auteur

Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: urgent need for standardization!

Archive ouverte | Guiu, Boris | CCSD

International audience

Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study.

Archive ouverte | Petit, Jean-Michel | CCSD

IF 5.455. International audience. Background:Nonalcoholic fatty liver disease is very frequent in type 2 diabetes, with increased risk of further development of liver fibrosis. Animal studies have shown that GLP-1 r...

GLP-1 receptor agonists in NAFLD.

Archive ouverte | Petit, Jean-Michel | CCSD

IF 4.101 . International audience. Non-alcoholic fatty liver disease (NAFLD) is very common in patients with type 2 diabetes (T2D), with approximately two-thirds having a diagnosis of the disease. Currently, the onl...

Chargement des enrichissements...